Padilla-Valverde, D.; Bodoque-Villar, R.; GarcÃa-Santos, E.; Sanchez, S.; Manzanares-Campillo, C.; Rodriguez, M.; González, L.; Ambrós, A.; Cano, J.M.; Padilla-Marcote, M.;
et al. Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41. Cancers 2024, 16, 1718.
https://doi.org/10.3390/cancers16091718
AMA Style
Padilla-Valverde D, Bodoque-Villar R, GarcÃa-Santos E, Sanchez S, Manzanares-Campillo C, Rodriguez M, González L, Ambrós A, Cano JM, Padilla-Marcote M,
et al. Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41. Cancers. 2024; 16(9):1718.
https://doi.org/10.3390/cancers16091718
Chicago/Turabian Style
Padilla-Valverde, David, Raquel Bodoque-Villar, Esther GarcÃa-Santos, Susana Sanchez, Carmen Manzanares-Campillo, Marta Rodriguez, Lucia González, Alfonso Ambrós, Juana M. Cano, Maria Padilla-Marcote,
and et al. 2024. "Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41" Cancers 16, no. 9: 1718.
https://doi.org/10.3390/cancers16091718
APA Style
Padilla-Valverde, D., Bodoque-Villar, R., GarcÃa-Santos, E., Sanchez, S., Manzanares-Campillo, C., Rodriguez, M., González, L., Ambrós, A., Cano, J. M., Padilla-Marcote, M., Redondo-Calvo, J., Martin, J., & Serrano-Oviedo, L.
(2024). Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41. Cancers, 16(9), 1718.
https://doi.org/10.3390/cancers16091718
